Rafferty Asset Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $763K | Sell |
50,957
-19,366
| -28% | -$290K | ﹤0.01% | 802 |
|
|
2025
Q1 | $1.13M | Sell |
70,323
-6,417
| -8% | -$104K | ﹤0.01% | 711 |
|
|
2024
Q4 | $1.79M | Buy |
76,740
+6,154
| +9% | +$143K | 0.01% | 674 |
|
|
2024
Q3 | $2.08M | Buy |
70,586
+3,477
| +5% | +$102K | 0.01% | 626 |
|
|
2024
Q2 | $1.58M | Buy |
+67,109
| New | +$1.58M | 0.01% | 705 |
|